Sofia Söllvander (2015)
Amyloid-β Protofibrils in Alzheimer´s Disease: Focus on Antibodies, Inflammation and Astrocytes

Elisabeth Jobs (2014)
Cathepsin S as a Biomarker of Low-grade Inflammation, Insulin Resistance, and Cardiometabolic Disease Risk

Ylva Cedervall (2014)
Physical Activity and Alzheimer's Disease: Measurements, Observations and Subjective Experiences

Astrid Gumucio (2014)
Therapeutic and functional studies in animal models of Alzheimer's disease

Elisabet Nerpin (2013)
The Kidney in Different Stages of the Cardiovascular Continuum

Therese Fagerqvist (2013)
Studies of α-synuclein Oligomers-with Relevance to Lewy Body Disorders

Malin Degerman Gunnarsson (2013)
Biomarkers as Monitors of Drug Effect, Diagnostic Tools and Predictors of Deterioration Rate in Alzheimer's Disease.

Elina Rönnemaa (2012)
Predictors of Dementia: Insulin, Fatty Acids and Vascular Risk Factors.

Thomas Näsström (2011)
Characterization of α-synuclein oligomers: Implications for Lewy Body Disorders.

Paul O'Callaghan (2011)
Heparan Sulfate in the Amyloidosis and Inflammation of Alzheimer’s Disease.

Johan Sundelöf (2010)
Amyloid ß-protein, Cystatin C and Cathepsin B as Biomarkers of Alzheimer's Disease.

Dag Sehlin (2010)
Aß Conformation Dependent Antibodies and Alzheimer's Disease.

Ola Philipson (2010)
Modeling Amyloid-ß Pathology in Alzheimer's Disease Using the Arctic Mutation.

Bernice Wiberg (2010)
Risk Factors for Stroke in Adult Men: A Population-based Study.

Hans-Erik Johansson (2010)
The Impact of Bariatric Surgery on Obesity related Metabolic Traits with Specific Emphasis on Glucose, Insulin and Proinsulin.

Lars Berglund (2009)
Measurement Variability Related to Insulin Secretion and Sensitivity: Assessment and Implications in Epidemiological Studies.

Hillevi Englund (2009)
Soluble amyloid-ß aggregates in Alzheimer's disease.

Anna Lord (2009)
Targeting Early Stages of Alzheimer's Disease in a Transgenic Model.

Lena Skoglund (2009)
Molecular Mechanisms of Frontotemporal Lobar Degeneration.

Elin Blom (2008)
Genetic Studies of Alzheimer's Disease.

Ann-Sofi Johansson (2007)
Amyloid beta Protofibril Formation and Neurotoxicity: Implications for Alzheimer's Disease.

Charlotte Sahlin (2007)
Pathogenic Mechanisms of the Arctic Alzheimer Mutation.

Erik Ingelsson (2005)
Insulin Resistance and Inflammation as Risk Factors for Congestive Heart Failure.

Kristina Dunder (2004)
Clinical Manifestations of Coronary Heart Disease and the Metabolic Syndrome: A Population-based Study in Middle-aged Men in Uppsala.

Anna Cristina Åberg (2003)
General Motor Function Assessment and Perceptions of Life Satisfaction during and after Geriatric Rehabilitation.

Björn Zethelius (2002)
Proinsulin and Insulin Sensitivity as Predictors of Type 2 Diabetes Mellitus and Coronary Heart Disease: Clinical Epidemiological Studies with up to 27 Years of Follow-Up.

Johan Ärnlöv (2002)
Left Ventricular Function in Elderly Men: Metabolic, Hormonal, Genetic and Prognostic Implications.

Kristina Björklund (2002)
24-hour Ambulatory Blood Pressure - Relation to the Insulin Resistance Syndrome and Cardiovascular Disease.

Liisa Byberg (2002)
Plasminogen Activator Inhibitor-1 and the Insulin Resistance Syndrome.

Arvo Hänni (2001)
Magnesium and the Insulin Resistance Syndrome.

Anu Hedman (2001)
Muscle Morphology and the Insulin Resistance Syndrome: A Population-Based Study of 70 Year-Old-Men in Uppsala.

Johan Sundström (2001)
Left ventricular hypertrophy and the insulin resistance syndrome.



Martin Ingelsson

018-471 4107

Dag Hammarskjölds väg 20, Uppsala

Rudbecklaboratoriet, 751 85 Uppsala